Synergy of two human endogenous retroviruses in multiple myeloma

Kathrine L M Schmidt1, Annette J Vangsted2, Bettina Hansen1

  • 1Department of Biomedicin, Aarhus University, DK-8000 Aarhus C, Denmark.

Leukemia Research
|August 2, 2015
PubMed

Insights

This study links human endogenous retroviral loci, HERV-Fc1 and HERV-K, to increased multiple myeloma (MM) risk. Genetic analysis revealed significant gene-gene interactions, suggesting a role for these retroviral elements in MM development.

Area of Science:

  • Genetics
  • Epidemiology
  • Oncology
  • Retroviral Research

Background:

  • Multiple myeloma (MM) is a serious, incurable plasma cell cancer.
  • The etiology of MM is not fully understood, prompting investigation into genetic risk factors.
  • Human endogenous retroviruses (HERVs) are remnants of ancient retroviral infections integrated into the human genome, with potential roles in disease.

Purpose of the Study:

  • To investigate the association between human endogenous retroviral loci and the risk of developing multiple myeloma.
  • To explore potential gene-gene interactions influencing MM susceptibility.
  • To utilize genetic epidemiology to identify novel risk factors for MM.

Main Methods:

  • Employed genetic epidemiology techniques to analyze risk factors for multiple myeloma.
  • Utilized Single Nucleotide Polymorphism (SNP) analysis on a Sequenom platform.
  • Performed statistical analysis using SPSS software to evaluate associations and interactions.

Main Results:

  • Identified significant associations between MM risk and genetic markers near two endogenous retroviral loci: HERV-Fc1 on chromosome X and HERV-K on chromosome 1.
  • Observed strong evidence of gene-gene interactions contributing to the risk of multiple myeloma.
  • These findings provide indirect confirmation of the association between specific HERV loci and MM.

Conclusions:

  • Genetic variations near HERV-Fc1 and HERV-K loci are associated with an increased risk of multiple myeloma.
  • Gene-gene interactions play a crucial role in the genetic susceptibility to MM.
  • This study supports the hypothesis that endogenous retroviral elements may contribute to the pathogenesis of multiple myeloma.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.1K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.1K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K